Yüklüyor......
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system and mainly affects young adults. Its natural history has changed in recent years with the advent of disease-modifying drugs, which have been available since the early 1990s. The increasing number of first-line a...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3699254/ https://ncbi.nlm.nih.gov/pubmed/23836975 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S45144 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|